Two Sigma Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $700M | Buy |
11,535,106
+6,873,064
| +147% | +$401M | 0.56% | 16 |
|
|
2025
Q4 | $251M | Sell |
4,662,042
-791,315
| -15% | -$38.1M | 0.35% | 26 |
|
|
2025
Q3 | $246M | Buy |
5,453,357
+4,588,601
| +531% | +$214M | 0.37% | 34 |
|
|
2025
Q2 | $40M | Buy |
864,756
+580,167
| +204% | +$28.5M | 0.07% | 341 |
|
|
2025
Q1 | $17.4M | Buy |
284,589
+198,965
| +232% | +$11.6M | 0.04% | 549 |
|
|
2024
Q4 | $4.84M | Sell |
85,624
-4,635,617
| -98% | -$259M | 0.01% | 1127 |
|
|
2024
Q3 | $244M | Sell |
4,721,241
-1,453,619
| -24% | -$68.2M | 0.54% | 16 |
|
|
2024
Q2 | $256M | Buy |
6,174,860
+1,577,529
| +34% | +$70.6M | 0.58% | 8 |
|
|
2024
Q1 | $249M | Sell |
4,597,331
-300,325
| -6% | -$15.3M | 0.59% | 9 |
|
|
2023
Q4 | $251M | Buy |
4,897,656
+835,524
| +21% | +$43.9M | 0.58% | 13 |
|
|
2023
Q3 | $236M | Buy |
4,062,132
+864,371
| +27% | +$53M | 0.63% | 13 |
|
|
2023
Q2 | $204M | Buy |
3,197,761
+1,352,338
| +73% | +$90.7M | 0.51% | 23 |
|
|
2023
Q1 | $128M | Buy |
1,845,423
+965,651
| +110% | +$68.1M | 0.37% | 65 |
|
|
2022
Q4 | $63.3M | Buy |
879,772
+512,671
| +140% | +$38.7M | 0.2% | 128 |
|
|
2022
Q3 | $26.1M | Sell |
367,101
-2,523,011
| -87% | -$183M | 0.09% | 270 |
|
|
2022
Q2 | $223M | Sell |
2,890,112
-37,541
| -1% | -$2.86M | 0.73% | 18 |
|
|
2022
Q1 | $214M | Sell |
2,927,653
-952,148
| -25% | -$63.9M | 0.63% | 17 |
|
|
2021
Q4 | $242M | Buy |
3,879,801
+174,412
| +5% | +$10.2M | 0.52% | 14 |
|
|
2021
Q3 | $219M | Buy |
3,705,389
+34,680
| +0.9% | +$2.28M | 0.49% | 21 |
|
|
2021
Q2 | $245M | Buy |
3,670,709
+3,078,135
| +519% | +$201M | 0.56% | 11 |
|
|
2021
Q1 | $37.4M | Buy |
592,574
+533,016
| +895% | +$33.2M | 0.1% | 240 |
|
|
2020
Q4 | $3.69M | Sell |
59,558
-920,457
| -94% | -$56.6M | 0.01% | 1107 |
|
|
2020
Q3 | $59.1M | Buy |
980,015
+283,829
| +41% | +$17.1M | 0.21% | 113 |
|
|
2020
Q2 | $40.9M | Buy |
696,186
+606,600
| +677% | +$36.3M | 0.2% | 101 |
|
|
2020
Q1 | $4.99M | Sell |
89,586
-1,203,503
| -93% | -$73.6M | 0.04% | 505 |
|
|
2019
Q4 | $83M | Sell |
1,293,089
-653,984
| -34% | -$37.5M | 0.25% | 84 |
|
|
2019
Q3 | $98.7M | Sell |
1,947,073
-846,469
| -30% | -$39.8M | 0.33% | 54 |
|
|
2019
Q2 | $127M | Sell |
2,793,542
-1,091,042
| -28% | -$50.8M | 0.42% | 35 |
|
|
2019
Q1 | $185M | Buy |
3,884,584
+3,291,232
| +555% | +$164M | 0.6% | 7 |
|
|
2018
Q4 | $30.8M | Buy |
593,352
+130,669
| +28% | +$7.02M | 0.12% | 228 |
|
|
2018
Q3 | $28.7M | Buy |
+462,683
| New | +$27.5M | 0.08% | 327 |
|
|
2018
Q2 | – | Sell |
-1,228,296
| Closed | -$66.3M | – | 3317 |
|
|
2018
Q1 | $77.7M | Buy |
1,228,296
+273,423
| +29% | +$17.6M | 0.26% | 95 |
|
|
2017
Q4 | $58.5M | Sell |
954,873
-758,234
| -44% | -$47.4M | 0.19% | 138 |
|
|
2017
Q3 | $109M | Sell |
1,713,107
-446,582
| -21% | -$26.1M | 0.39% | 56 |
|
|
2017
Q2 | $120M | Buy |
2,159,689
+1,102,785
| +104% | +$60M | 0.44% | 37 |
|
|
2017
Q1 | $57.5M | Buy |
1,056,904
+1,033,891
| +4,493% | +$56.7M | 0.19% | 130 |
|
|
2016
Q4 | $1.34M | Sell |
23,013
-98,881
| -81% | -$5.41M | 0.01% | 1787 |
|
|
2016
Q3 | $6.57M | Buy |
121,894
+116,551
| +2,181% | +$7.49M | 0.02% | 745 |
|
|
2016
Q2 | $393K | Sell |
5,343
-2,841
| -35% | -$201K | ﹤0.01% | 2405 |
|
|
2016
Q1 | $523K | Buy |
8,184
+4,904
| +150% | +$309K | ﹤0.01% | 2031 |
|
|
2015
Q4 | $226K | Sell |
3,280
-53,172
| -94% | -$3.51M | ﹤0.01% | 2395 |
|
|
2015
Q3 | $3.34M | Buy |
+56,452
| New | +$3.58M | 0.02% | 655 |
|
|
2014
Q4 | – | Sell |
-535,196
| Closed | -$27.4M | – | 2229 |
|
|
2014
Q3 | $27.4M | Sell |
535,196
-220,660
| -29% | -$11M | 0.12% | 236 |
|
|
2014
Q2 | $36.7M | Buy |
+755,856
| New | +$37.2M | 0.17% | 172 |
|
|
2013
Q4 | – | Sell |
-145,518
| Closed | -$6.74M | – | 2181 |
|
|
2013
Q3 | $6.74M | Buy |
+145,518
| New | +$6.39M | 0.04% | 443 |
|
Other funds holding BMY
VCM
VPM
Two Sigma Investments's BMY Position: Q1 2026 in Review
Two Sigma Investments increased its Bristol-Myers Squibb (BMY) stake by 147% in Q1 2026, buying an estimated $401M and bringing the position to 11,535,106 shares worth $700M. The position accounts for 0.56% of the portfolio, ranked #16.
Two Sigma Investments first reported a position in BMY in Q3 2013 and has held it in 45 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Two Sigma Investments held 11,535,106 shares of Bristol-Myers Squibb worth $700M as of Q1 2026.
- Two Sigma Investments bought 6,873,064 Bristol-Myers Squibb shares in Q1 2026, an estimated $401M.
- Bristol-Myers Squibb made up 0.56% of Two Sigma Investments's portfolio in Q1 2026, its #16 holding.
- Two Sigma Investments first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 45 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.